(Q35585098)

9 August 2017

1 reference

title

Cathelicidins and innate defense against invasive bacterial infection (English)

1 reference

9 August 2017

Cathelicidins and Innate Defense Against Invasive Bacterial Infection (English)

1 reference

10.1080/00365540310015629

DOI

https://api.crossref.org/works/10.1080/00365540310015629

2 April 2024

1

Victor Nizet

0 references

Richard Gallo

series ordinal

2

object named as

Richard L Gallo

1 reference

9 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14620153

2 April 2024

publication date

1 January 2003

1 reference

9 August 2017

1 reference

9 August 2017

volume

35

1 reference

9 August 2017

issue

9

1 reference

9 August 2017

page(s)

670-676

1 reference

Cathelicidins: microbicidal activity, mechanisms of action, and roles in innate immunity

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Cathelicidins, essential gene-encoded mammalian antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Structure and biology of cathelicidins

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

The human gene FALL39 and processing of the cathelin precursor to the antibacterial peptide LL-37 in granulocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Biology and clinical relevance of naturally occurring antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Cathelicidin antimicrobial peptides are expressed in salivary glands and saliva

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Cathelicidin anti-microbial peptide expression in sweat, an innate defense system for the skin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

How do bacteria resist human antimicrobial peptides?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Modulation of Neisseria gonorrhoeae susceptibility to vertebrate antibacterial peptides due to a member of the resistance/nodulation/division efflux pump family

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Staphylococcus aureus strains lacking D-alanine modifications of teichoic acids are highly susceptible to human neutrophil killing and are virulence attenuated in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Innate antimicrobial peptide protects the skin from invasive bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Inhibition of neutrophil elastase prevents cathelicidin activation and impairs clearance of bacteria from wounds

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Killing activity of neutrophils is mediated through activation of proteases by K+ flux

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

The ovine cathelicidin SMAP29 kills ovine respiratory pathogens in vitro and in an ovine model of pulmonary infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Antimicrobial peptide LL-37 is upregulated in chronic nasal inflammatory disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Endogenous antimicrobial peptides and skin infections in atopic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Neonatal skin in mice and humans expresses increased levels of antimicrobial peptides: innate immunity during development of the adaptive response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Cystic fibrosis airway epithelia fail to kill bacteria because of abnormal airway surface fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Human beta-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

The peptide antibiotic LL-37/hCAP-18 is expressed in epithelia of the human lung where it has broad antimicrobial activity at the airway surface

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Exploitation of syndecan-1 shedding by Pseudomonas aeruginosa enhances virulence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Structural features and biological activities of the cathelicidin-derived antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Syndecan-1 Shedding Is Enhanced by LasA, a Secreted Virulence Factor ofPseudomonas aeruginosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

The newborn infant is protected by an innate antimicrobial barrier: peptide antibiotics are present in the skin and vernix caseosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Development of protegrins for the treatment and prevention of oral mucositis: structure-activity relationships of synthetic protegrin analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00365540310015629

Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein

21 January 2018

series ordinal

8

1 reference

10.1080/00365540310015629

DOI

https://api.crossref.org/works/10.1080/00365540310015629

10.1080/00365540310015629

2 April 2024

Identifiers

DOI

1 reference

9 August 2017

1 reference